Hélène Haegel-Kronenberger

Suggest Changes
Learn More
Blockade of the CD40–CD40L and CD80/CD86–CD28 costimulatory pathways represents a strategy to inhibit the immune response against Ad vectors designed for gene therapy applications. Since most(More)
  • 1